

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic transmission, dopaminergic (GO:0001963) | 6.66568316 |
| 2 | prepulse inhibition (GO:0060134) | 6.41853234 |
| 3 | regulation of synapse structural plasticity (GO:0051823) | 6.35714187 |
| 4 | adenosine receptor signaling pathway (GO:0001973) | 5.85730525 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.82735211 |
| 6 | striatum development (GO:0021756) | 5.59099170 |
| 7 | synaptic vesicle maturation (GO:0016188) | 5.52095599 |
| 8 | locomotory exploration behavior (GO:0035641) | 5.50208211 |
| 9 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 5.44319231 |
| 10 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.17819798 |
| 11 | sodium ion export (GO:0071436) | 5.15992159 |
| 12 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 5.13010642 |
| 13 | auditory behavior (GO:0031223) | 5.09351343 |
| 14 | vocalization behavior (GO:0071625) | 4.98535519 |
| 15 | dopamine receptor signaling pathway (GO:0007212) | 4.85454442 |
| 16 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.83502664 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.80989262 |
| 18 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.79983390 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.78163282 |
| 20 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.75830162 |
| 21 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.74587652 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.68942656 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.66660563 |
| 24 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.64754875 |
| 25 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.63528230 |
| 26 | behavioral response to cocaine (GO:0048148) | 4.56271234 |
| 27 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.50893290 |
| 28 | positive regulation of neurotransmitter transport (GO:0051590) | 4.46314043 |
| 29 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.43842881 |
| 30 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.43842881 |
| 31 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.43074097 |
| 32 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.43074097 |
| 33 | neuromuscular process controlling balance (GO:0050885) | 4.38738018 |
| 34 | response to auditory stimulus (GO:0010996) | 4.33057165 |
| 35 | * response to amphetamine (GO:0001975) | 4.32094544 |
| 36 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.31222543 |
| 37 | cAMP catabolic process (GO:0006198) | 4.22740379 |
| 38 | regulation of glutamate secretion (GO:0014048) | 4.21168252 |
| 39 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.16918566 |
| 40 | dendritic spine morphogenesis (GO:0060997) | 4.16254623 |
| 41 | synaptic vesicle exocytosis (GO:0016079) | 4.10149659 |
| 42 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 4.08653688 |
| 43 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.06107732 |
| 44 | neuron-neuron synaptic transmission (GO:0007270) | 4.03890830 |
| 45 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.02130177 |
| 46 | regulation of cholesterol homeostasis (GO:2000188) | 3.99366460 |
| 47 | neurotransmitter secretion (GO:0007269) | 3.99023917 |
| 48 | cerebellar granule cell differentiation (GO:0021707) | 3.96827798 |
| 49 | regulation of neurotransmitter uptake (GO:0051580) | 3.95802425 |
| 50 | positive regulation of synapse maturation (GO:0090129) | 3.95183776 |
| 51 | exploration behavior (GO:0035640) | 3.94196946 |
| 52 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.94034328 |
| 53 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.93537979 |
| 54 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.93074171 |
| 55 | neuronal ion channel clustering (GO:0045161) | 3.92938591 |
| 56 | peristalsis (GO:0030432) | 3.92234587 |
| 57 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.91086141 |
| 58 | long-term memory (GO:0007616) | 3.88893097 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.86038226 |
| 60 | positive regulation of membrane potential (GO:0045838) | 3.84907698 |
| 61 | transmission of nerve impulse (GO:0019226) | 3.84106107 |
| 62 | neuronal action potential propagation (GO:0019227) | 3.78804368 |
| 63 | protein localization to synapse (GO:0035418) | 3.77186748 |
| 64 | cyclic nucleotide catabolic process (GO:0009214) | 3.71915529 |
| 65 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.71708814 |
| 66 | gamma-aminobutyric acid transport (GO:0015812) | 3.70163119 |
| 67 | synaptic transmission, glutamatergic (GO:0035249) | 3.69597956 |
| 68 | L-amino acid import (GO:0043092) | 3.68257279 |
| 69 | regulation of synaptic plasticity (GO:0048167) | 3.67589028 |
| 70 | layer formation in cerebral cortex (GO:0021819) | 3.66844002 |
| 71 | mechanosensory behavior (GO:0007638) | 3.64903848 |
| 72 | behavioral fear response (GO:0001662) | 3.60835550 |
| 73 | behavioral defense response (GO:0002209) | 3.60835550 |
| 74 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.60786219 |
| 75 | membrane hyperpolarization (GO:0060081) | 3.60231889 |
| 76 | cAMP metabolic process (GO:0046058) | 3.59046484 |
| 77 | regulation of postsynaptic membrane potential (GO:0060078) | 3.58771082 |
| 78 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.58769396 |
| 79 | drinking behavior (GO:0042756) | 3.58352979 |
| 80 | glycine transport (GO:0015816) | 3.58039933 |
| 81 | regulation of ARF protein signal transduction (GO:0032012) | 3.57417047 |
| 82 | regulation of norepinephrine secretion (GO:0014061) | 3.53486399 |
| 83 | proline metabolic process (GO:0006560) | 3.52172768 |
| 84 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.51256699 |
| 85 | regulation of synaptic vesicle transport (GO:1902803) | 3.50654500 |
| 86 | negative regulation of dendrite development (GO:2000171) | 3.49414012 |
| 87 | neurotransmitter transport (GO:0006836) | 3.48471222 |
| 88 | activation of protein kinase A activity (GO:0034199) | 3.47408527 |
| 89 | long-term synaptic potentiation (GO:0060291) | 3.47224443 |
| 90 | response to histamine (GO:0034776) | 3.44228495 |
| 91 | axon ensheathment in central nervous system (GO:0032291) | 3.42093831 |
| 92 | central nervous system myelination (GO:0022010) | 3.42093831 |
| 93 | potassium ion homeostasis (GO:0055075) | 3.39472659 |
| 94 | regulation of dendritic spine development (GO:0060998) | 3.38493766 |
| 95 | mating behavior (GO:0007617) | 3.38035500 |
| 96 | glutamate receptor signaling pathway (GO:0007215) | 3.33369487 |
| 97 | cellular sodium ion homeostasis (GO:0006883) | 3.31860306 |
| 98 | negative regulation of amino acid transport (GO:0051956) | 3.30794921 |
| 99 | synaptic vesicle endocytosis (GO:0048488) | 3.29866159 |
| 100 | * visual learning (GO:0008542) | 3.29741133 |
| 101 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.29153444 |
| 102 | glutamate secretion (GO:0014047) | 3.25709284 |
| 103 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.25498532 |
| 104 | cAMP biosynthetic process (GO:0006171) | 3.25413661 |
| 105 | epithelial structure maintenance (GO:0010669) | 3.24910887 |
| 106 | cGMP metabolic process (GO:0046068) | 3.22061199 |
| 107 | amino acid import (GO:0043090) | 3.21298699 |
| 108 | regulation of synapse maturation (GO:0090128) | 3.20924197 |
| 109 | positive regulation of synaptic transmission (GO:0050806) | 3.18495808 |
| 110 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.18365355 |
| 111 | fear response (GO:0042596) | 3.17183436 |
| 112 | regulation of bile acid biosynthetic process (GO:0070857) | 3.16144264 |
| 113 | potassium ion import (GO:0010107) | 3.15969333 |
| 114 | neuromuscular process (GO:0050905) | 3.15563144 |
| 115 | regulation of protein kinase A signaling (GO:0010738) | 3.14591723 |
| 116 | * regulation of female receptivity (GO:0045924) | 3.11466614 |
| 117 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.11411062 |
| 118 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.11174917 |
| 119 | cellular potassium ion homeostasis (GO:0030007) | 3.10832675 |
| 120 | * visual behavior (GO:0007632) | 3.09386826 |
| 121 | myelin maintenance (GO:0043217) | 3.08866207 |
| 122 | membrane depolarization (GO:0051899) | 3.07883728 |
| 123 | regulation of neurotransmitter levels (GO:0001505) | 3.06718127 |
| 124 | dendritic spine organization (GO:0097061) | 3.06485407 |
| 125 | positive regulation of dendritic spine development (GO:0060999) | 3.04989372 |
| 126 | lung epithelium development (GO:0060428) | 3.01197133 |
| 127 | cell communication by electrical coupling (GO:0010644) | 3.00173324 |
| 128 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.98003164 |
| 129 | long term synaptic depression (GO:0060292) | 2.94671372 |
| 130 | cell communication involved in cardiac conduction (GO:0086065) | 2.91674726 |
| 131 | stress granule assembly (GO:0034063) | 2.91156635 |
| 132 | regulation of neurotransmitter secretion (GO:0046928) | 2.80458778 |
| 133 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.75767973 |
| 134 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.75640644 |
| 135 | acidic amino acid transport (GO:0015800) | 2.73993802 |
| 136 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.72322994 |
| 137 | semaphorin-plexin signaling pathway (GO:0071526) | 2.70075026 |
| 138 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.66740489 |
| 139 | sodium ion homeostasis (GO:0055078) | 2.63705255 |
| 140 | filopodium assembly (GO:0046847) | 2.63207955 |
| 141 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.60828867 |
| 142 | cardiac conduction (GO:0061337) | 2.58167096 |
| 143 | * female mating behavior (GO:0060180) | 2.57789835 |
| 144 | regulation of ARF GTPase activity (GO:0032312) | 2.54841991 |
| 145 | vesicle docking involved in exocytosis (GO:0006904) | 2.50907234 |
| 146 | neuromuscular process controlling posture (GO:0050884) | 2.50840130 |
| 147 | L-glutamate transport (GO:0015813) | 2.49396748 |
| 148 | cerebellar Purkinje cell layer development (GO:0021680) | 2.49053384 |
| 149 | regulation of neurotransmitter transport (GO:0051588) | 2.49031815 |
| 150 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.44643582 |
| 151 | cGMP-mediated signaling (GO:0019934) | 2.43657316 |
| 152 | regulation of respiratory burst (GO:0060263) | 2.42052076 |
| 153 | synaptic vesicle transport (GO:0048489) | 2.40998734 |
| 154 | establishment of synaptic vesicle localization (GO:0097480) | 2.40998734 |
| 155 | proline transport (GO:0015824) | 2.40375708 |
| 156 | regulation of synaptic transmission (GO:0050804) | 2.38982735 |
| 157 | ethanol metabolic process (GO:0006067) | 2.38903809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.62763274 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 4.39102886 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.26065316 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09879150 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.09848078 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.93637754 |
| 7 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.86716742 |
| 8 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.83472541 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.79123910 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.72952137 |
| 11 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.72952137 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.67167974 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.64249022 |
| 14 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.63751413 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.62279537 |
| 16 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.57878453 |
| 17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.57507254 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.52149035 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.50608092 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.39248968 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.38785062 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.37409011 |
| 23 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.29885905 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.27809581 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.23304059 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19455635 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.19076755 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.98819779 |
| 29 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.98599808 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.88904088 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.87821420 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.83457575 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75875838 |
| 34 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.66519307 |
| 35 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.66184988 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.65239948 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61952056 |
| 38 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.57618215 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.54815737 |
| 40 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.54614843 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.54267258 |
| 42 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.52082729 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.51039317 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49824646 |
| 45 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.46808145 |
| 46 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.44146601 |
| 47 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.42516246 |
| 48 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.40477163 |
| 49 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.39158185 |
| 50 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.38012859 |
| 51 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35316645 |
| 52 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.35300227 |
| 53 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34698241 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.34044673 |
| 55 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33628639 |
| 56 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32600233 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30943465 |
| 58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29709013 |
| 59 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.28738413 |
| 60 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.28225913 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27759776 |
| 62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.26232108 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.26226825 |
| 64 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.25096036 |
| 65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23480172 |
| 66 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22349437 |
| 67 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20721160 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20481051 |
| 69 | P68_20966046_ChIP-Seq_HELA_Human | 1.19813177 |
| 70 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19403048 |
| 71 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19159873 |
| 72 | AR_19668381_ChIP-Seq_PC3_Human | 1.15952311 |
| 73 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.14732719 |
| 74 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.14672198 |
| 75 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14481272 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12988353 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12320578 |
| 78 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11997057 |
| 79 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11657754 |
| 80 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08334573 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07686047 |
| 82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07607298 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07179930 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06185170 |
| 85 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.05996545 |
| 86 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05905643 |
| 87 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04557505 |
| 88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04530635 |
| 89 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04249831 |
| 90 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02903821 |
| 91 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.01172861 |
| 92 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01144729 |
| 93 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00938819 |
| 94 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99516593 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99098881 |
| 96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.98327650 |
| 97 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98205950 |
| 98 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98188696 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97462867 |
| 100 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.97267722 |
| 101 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.96801217 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95261613 |
| 103 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94878103 |
| 104 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.93233921 |
| 105 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.92377226 |
| 106 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91396588 |
| 107 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91322493 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91119459 |
| 109 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91008177 |
| 110 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.90703728 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 0.90284354 |
| 112 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90153454 |
| 113 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.89087125 |
| 114 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88814959 |
| 115 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87969964 |
| 116 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.87214635 |
| 117 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87137722 |
| 118 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87129429 |
| 119 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86973961 |
| 120 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.86474573 |
| 121 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.86355384 |
| 122 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86228677 |
| 123 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.85289127 |
| 124 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.84990292 |
| 125 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84844631 |
| 126 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.83646132 |
| 127 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.83185128 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.83064820 |
| 129 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82158173 |
| 130 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.81628996 |
| 131 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81219594 |
| 132 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.80823575 |
| 133 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.80008253 |
| 134 | TCF4_23295773_ChIP-Seq_U87_Human | 0.79176513 |
| 135 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79004209 |
| 136 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.77655008 |
| 137 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.77126054 |
| 138 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.76227947 |
| 139 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76004619 |
| 140 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75658967 |
| 141 | AR_25329375_ChIP-Seq_VCAP_Human | 0.75555041 |
| 142 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.75247553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.29433052 |
| 2 | * MP0003635_abnormal_synaptic_transmissio | 3.97039194 |
| 3 | MP0003880_abnormal_central_pattern | 3.69388428 |
| 4 | * MP0009745_abnormal_behavioral_response | 3.57908715 |
| 5 | * MP0002063_abnormal_learning/memory/cond | 3.34938742 |
| 6 | MP0004270_analgesia | 3.14656358 |
| 7 | MP0002064_seizures | 2.91864362 |
| 8 | MP0001529_abnormal_vocalization | 2.89893336 |
| 9 | MP0001486_abnormal_startle_reflex | 2.73697946 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.72165285 |
| 11 | MP0009046_muscle_twitch | 2.67605192 |
| 12 | MP0002909_abnormal_adrenal_gland | 2.60817949 |
| 13 | MP0002272_abnormal_nervous_system | 2.40569200 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.26170249 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.24036715 |
| 16 | MP0005670_abnormal_white_adipose | 2.14474729 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.07539007 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.03381247 |
| 19 | MP0002822_catalepsy | 10.0684685 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 1.92969647 |
| 21 | MP0005409_darkened_coat_color | 1.77378305 |
| 22 | MP0001970_abnormal_pain_threshold | 1.72613303 |
| 23 | MP0008569_lethality_at_weaning | 1.72307692 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.65225265 |
| 25 | MP0003075_altered_response_to | 1.64175907 |
| 26 | * MP0004924_abnormal_behavior | 1.63250739 |
| 27 | * MP0005386_behavior/neurological_phenoty | 1.63250739 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.62409612 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.60831757 |
| 30 | MP0004811_abnormal_neuron_physiology | 1.59772239 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.59445969 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.56307761 |
| 33 | MP0001984_abnormal_olfaction | 1.55396242 |
| 34 | MP0001849_ear_inflammation | 1.52684077 |
| 35 | MP0005365_abnormal_bile_salt | 1.51108301 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.49392792 |
| 37 | MP0002736_abnormal_nociception_after | 1.47277679 |
| 38 | MP0003879_abnormal_hair_cell | 1.45583259 |
| 39 | MP0001188_hyperpigmentation | 1.42608012 |
| 40 | MP0004885_abnormal_endolymph | 1.41932108 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.39799803 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.38227290 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.36120389 |
| 44 | MP0000566_synostosis | 1.35250955 |
| 45 | MP0002067_abnormal_sensory_capabilities | 1.33521312 |
| 46 | MP0003283_abnormal_digestive_organ | 1.32278180 |
| 47 | MP0001177_atelectasis | 1.30807744 |
| 48 | MP0003329_amyloid_beta_deposits | 1.30469193 |
| 49 | MP0003633_abnormal_nervous_system | 1.27860211 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.25231283 |
| 51 | MP0003938_abnormal_ear_development | 1.24673209 |
| 52 | MP0003123_paternal_imprinting | 1.23642176 |
| 53 | * MP0002066_abnormal_motor_capabilities/c | 1.21003770 |
| 54 | MP0000678_abnormal_parathyroid_gland | 1.19313282 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.17099410 |
| 56 | MP0002249_abnormal_larynx_morphology | 1.15443493 |
| 57 | MP0001905_abnormal_dopamine_level | 1.15253631 |
| 58 | MP0000955_abnormal_spinal_cord | 1.13980313 |
| 59 | * MP0008874_decreased_physiological_sensi | 1.13590070 |
| 60 | MP0009379_abnormal_foot_pigmentation | 1.09419008 |
| 61 | MP0004264_abnormal_extraembryonic_tissu | 1.08465586 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.08211975 |
| 63 | MP0006276_abnormal_autonomic_nervous | 1.07300479 |
| 64 | MP0003690_abnormal_glial_cell | 1.06382223 |
| 65 | MP0004147_increased_porphyrin_level | 1.06209089 |
| 66 | MP0002184_abnormal_innervation | 1.05692275 |
| 67 | MP0004085_abnormal_heartbeat | 1.04167478 |
| 68 | MP0002882_abnormal_neuron_morphology | 1.02128871 |
| 69 | MP0002089_abnormal_postnatal_growth/wei | 0.99919569 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 0.99900241 |
| 71 | MP0003172_abnormal_lysosome_physiology | 0.99313315 |
| 72 | MP0004130_abnormal_muscle_cell | 0.98409050 |
| 73 | MP0004858_abnormal_nervous_system | 0.97612774 |
| 74 | MP0002735_abnormal_chemical_nociception | 0.96981577 |
| 75 | MP0003631_nervous_system_phenotype | 0.95276115 |
| 76 | MP0005535_abnormal_body_temperature | 0.95020521 |
| 77 | MP0002090_abnormal_vision | 0.92972433 |
| 78 | * MP0008872_abnormal_physiological_respon | 0.92099634 |
| 79 | * MP0002069_abnormal_eating/drinking_beha | 0.90653320 |
| 80 | MP0004043_abnormal_pH_regulation | 0.90477585 |
| 81 | MP0004084_abnormal_cardiac_muscle | 0.90476611 |
| 82 | MP0004019_abnormal_vitamin_homeostasis | 0.89892187 |
| 83 | MP0001502_abnormal_circadian_rhythm | 0.88990881 |
| 84 | MP0003045_fibrosis | 0.88690233 |
| 85 | MP0005375_adipose_tissue_phenotype | 0.86672386 |
| 86 | MP0000920_abnormal_myelination | 0.84373190 |
| 87 | MP0000778_abnormal_nervous_system | 0.82179056 |
| 88 | MP0000537_abnormal_urethra_morphology | 0.81520923 |
| 89 | MP0002152_abnormal_brain_morphology | 0.80282174 |
| 90 | MP0003137_abnormal_impulse_conducting | 0.79834151 |
| 91 | MP0004142_abnormal_muscle_tone | 0.79623287 |
| 92 | MP0004036_abnormal_muscle_relaxation | 0.78433548 |
| 93 | MP0000751_myopathy | 0.77615652 |
| 94 | MP0010329_abnormal_lipoprotein_level | 0.77048448 |
| 95 | MP0002971_abnormal_brown_adipose | 0.76850346 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 0.76541585 |
| 97 | MP0005166_decreased_susceptibility_to | 0.76352835 |
| 98 | MP0001664_abnormal_digestion | 0.75205920 |
| 99 | MP0005394_taste/olfaction_phenotype | 0.75169924 |
| 100 | MP0005499_abnormal_olfactory_system | 0.75169924 |
| 101 | MP0003787_abnormal_imprinting | 0.74660810 |
| 102 | MP0005058_abnormal_lysosome_morphology | 0.74605704 |
| 103 | MP0005360_urolithiasis | 0.73620488 |
| 104 | MP0000579_abnormal_nail_morphology | 0.72344061 |
| 105 | MP0002229_neurodegeneration | 0.67691872 |
| 106 | MP0000569_abnormal_digit_pigmentation | 0.65870749 |
| 107 | MP0001485_abnormal_pinna_reflex | 0.64303895 |
| 108 | MP0000631_abnormal_neuroendocrine_gland | 0.60167848 |
| 109 | MP0003634_abnormal_glial_cell | 0.59068253 |
| 110 | MP0000604_amyloidosis | 0.58801810 |
| 111 | MP0005645_abnormal_hypothalamus_physiol | 0.57366584 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.55233498 |
| 113 | MP0003300_gastrointestinal_ulcer | 0.51511472 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.50090119 |
| 115 | MP0003632_abnormal_nervous_system | 0.48084776 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 0.45289901 |
| 117 | MP0001943_abnormal_respiration | 0.44269863 |
| 118 | MP0003956_abnormal_body_size | 0.43962858 |
| 119 | MP0003866_abnormal_defecation | 0.43764044 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.41217065 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.40972962 |
| 122 | MP0005448_abnormal_energy_balance | 0.39220664 |
| 123 | MP0005620_abnormal_muscle_contractility | 0.38832848 |
| 124 | MP0004742_abnormal_vestibular_system | 0.37394175 |
| 125 | MP0010769_abnormal_survival | 0.35449883 |
| 126 | MP0001963_abnormal_hearing_physiology | 0.34661057 |
| 127 | MP0000534_abnormal_ureter_morphology | 0.34581859 |
| 128 | MP0010770_preweaning_lethality | 0.33262057 |
| 129 | MP0002082_postnatal_lethality | 0.33262057 |
| 130 | MP0001666_abnormal_nutrient_absorption | 0.32505542 |
| 131 | MP0010768_mortality/aging | 0.32311010 |
| 132 | MP0002752_abnormal_somatic_nervous | 0.32201419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 9.81763177 |
| 2 | Focal motor seizures (HP:0011153) | 7.36417962 |
| 3 | Focal seizures (HP:0007359) | 5.52475118 |
| 4 | Annular pancreas (HP:0001734) | 5.19258775 |
| 5 | Resting tremor (HP:0002322) | 4.94257105 |
| 6 | Torticollis (HP:0000473) | 4.78149120 |
| 7 | Ependymoma (HP:0002888) | 4.23660477 |
| 8 | Hydroxyprolinuria (HP:0003080) | 4.20767695 |
| 9 | Abnormality of proline metabolism (HP:0010907) | 4.20767695 |
| 10 | Poor eye contact (HP:0000817) | 4.18428113 |
| 11 | Focal dystonia (HP:0004373) | 4.12208273 |
| 12 | Anxiety (HP:0000739) | 4.08872260 |
| 13 | Action tremor (HP:0002345) | 4.08203312 |
| 14 | Craniofacial dystonia (HP:0012179) | 4.07355621 |
| 15 | Ankyloglossia (HP:0010296) | 4.03139376 |
| 16 | Visual hallucinations (HP:0002367) | 3.98374734 |
| 17 | Ankle clonus (HP:0011448) | 3.90526291 |
| 18 | Abnormal social behavior (HP:0012433) | 3.84047967 |
| 19 | Impaired social interactions (HP:0000735) | 3.84047967 |
| 20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.74086402 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.69913991 |
| 22 | Depression (HP:0000716) | 3.67667671 |
| 23 | Broad-based gait (HP:0002136) | 3.45361850 |
| 24 | Prolonged QT interval (HP:0001657) | 3.40539503 |
| 25 | Polygenic inheritance (HP:0010982) | 3.38441617 |
| 26 | Dysdiadochokinesis (HP:0002075) | 3.37196682 |
| 27 | Epileptic encephalopathy (HP:0200134) | 3.31799887 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 3.28476889 |
| 29 | Pointed chin (HP:0000307) | 3.26840263 |
| 30 | Astrocytoma (HP:0009592) | 3.25745889 |
| 31 | Abnormality of the astrocytes (HP:0100707) | 3.25745889 |
| 32 | Stereotypic behavior (HP:0000733) | 3.24234797 |
| 33 | Decreased circulating renin level (HP:0003351) | 3.23161572 |
| 34 | Bronchomalacia (HP:0002780) | 3.20936839 |
| 35 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.17898980 |
| 36 | Hyperactive renin-angiotensin system (HP:0000841) | 3.17136112 |
| 37 | Lower limb amyotrophy (HP:0007210) | 3.11490282 |
| 38 | Ventricular fibrillation (HP:0001663) | 3.11148182 |
| 39 | Urinary urgency (HP:0000012) | 3.08348004 |
| 40 | Abnormality of renin-angiotensin system (HP:0000847) | 3.07270464 |
| 41 | Gaze-evoked nystagmus (HP:0000640) | 3.06408639 |
| 42 | Dysmetric saccades (HP:0000641) | 3.03796544 |
| 43 | Febrile seizures (HP:0002373) | 3.02725598 |
| 44 | Atrioventricular block (HP:0001678) | 3.02488124 |
| 45 | Metabolic alkalosis (HP:0200114) | 3.01615823 |
| 46 | Abnormal EKG (HP:0003115) | 2.98571254 |
| 47 | Absence seizures (HP:0002121) | 2.96584208 |
| 48 | Stomach cancer (HP:0012126) | 2.96226455 |
| 49 | Diplopia (HP:0000651) | 2.95650568 |
| 50 | Abnormality of binocular vision (HP:0011514) | 2.95650568 |
| 51 | Abnormality of oral frenula (HP:0000190) | 2.94912884 |
| 52 | Postural instability (HP:0002172) | 2.93972087 |
| 53 | Papilledema (HP:0001085) | 2.93058897 |
| 54 | Dysmetria (HP:0001310) | 2.91025961 |
| 55 | Scanning speech (HP:0002168) | 2.88723477 |
| 56 | Dialeptic seizures (HP:0011146) | 2.79644415 |
| 57 | Upper limb amyotrophy (HP:0009129) | 2.79350890 |
| 58 | Distal upper limb amyotrophy (HP:0007149) | 2.79350890 |
| 59 | Abnormal eating behavior (HP:0100738) | 2.77925866 |
| 60 | Distal lower limb amyotrophy (HP:0008944) | 2.74188012 |
| 61 | Visceral angiomatosis (HP:0100761) | 2.67123211 |
| 62 | Megalencephaly (HP:0001355) | 2.66891411 |
| 63 | Intention tremor (HP:0002080) | 2.66193151 |
| 64 | Heart block (HP:0012722) | 2.65470929 |
| 65 | Cerebral aneurysm (HP:0004944) | 2.62502806 |
| 66 | Abnormality of the lower motor neuron (HP:0002366) | 2.61467762 |
| 67 | Limb hypertonia (HP:0002509) | 2.58857303 |
| 68 | Truncal ataxia (HP:0002078) | 2.58577475 |
| 69 | Spastic gait (HP:0002064) | 2.55583042 |
| 70 | Axonal loss (HP:0003447) | 2.54576612 |
| 71 | Supranuclear gaze palsy (HP:0000605) | 2.52888016 |
| 72 | Atonic seizures (HP:0010819) | 2.52712649 |
| 73 | Impaired vibratory sensation (HP:0002495) | 2.51284531 |
| 74 | Akinesia (HP:0002304) | 2.49364481 |
| 75 | Progressive cerebellar ataxia (HP:0002073) | 2.47728968 |
| 76 | Bradykinesia (HP:0002067) | 2.45663295 |
| 77 | Hyperparathyroidism (HP:0000843) | 2.45074571 |
| 78 | Limb dystonia (HP:0002451) | 2.43801615 |
| 79 | Clonus (HP:0002169) | 2.43682568 |
| 80 | Abnormal atrioventricular conduction (HP:0005150) | 2.43351506 |
| 81 | Impaired smooth pursuit (HP:0007772) | 2.42079037 |
| 82 | Hemangiomatosis (HP:0007461) | 2.38322924 |
| 83 | Syncope (HP:0001279) | 2.35876228 |
| 84 | Bundle branch block (HP:0011710) | 2.30976139 |
| 85 | Mutism (HP:0002300) | 2.29713339 |
| 86 | Status epilepticus (HP:0002133) | 2.27047000 |
| 87 | Neonatal short-limb short stature (HP:0008921) | 2.26530305 |
| 88 | Lymphangioma (HP:0100764) | 2.25554187 |
| 89 | Incomplete penetrance (HP:0003829) | 2.23647149 |
| 90 | Lower limb asymmetry (HP:0100559) | 2.21638288 |
| 91 | Hyperaldosteronism (HP:0000859) | 2.20983914 |
| 92 | Truncus arteriosus (HP:0001660) | 2.20793493 |
| 93 | Hyperglycinuria (HP:0003108) | 2.20734451 |
| 94 | Hemiplegia (HP:0002301) | 2.15525557 |
| 95 | Amblyopia (HP:0000646) | 2.15391967 |
| 96 | Obstructive sleep apnea (HP:0002870) | 2.14951654 |
| 97 | Glioma (HP:0009733) | 2.11960111 |
| 98 | Right ventricular cardiomyopathy (HP:0011663) | 2.09656815 |
| 99 | Hyperventilation (HP:0002883) | 2.07808521 |
| 100 | Tetraplegia (HP:0002445) | 2.06356143 |
| 101 | Sleep apnea (HP:0010535) | 2.05932310 |
| 102 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.03221153 |
| 103 | Lower limb muscle weakness (HP:0007340) | 2.03021514 |
| 104 | Neuronal loss in central nervous system (HP:0002529) | 2.01889864 |
| 105 | Abnormality of the periventricular white matter (HP:0002518) | 2.01884863 |
| 106 | Nuclear cataract (HP:0100018) | 2.01004017 |
| 107 | Malnutrition (HP:0004395) | 2.00844440 |
| 108 | Spinal canal stenosis (HP:0003416) | 2.00823494 |
| 109 | Dysphonia (HP:0001618) | 2.00220645 |
| 110 | Hemiparesis (HP:0001269) | 1.99408056 |
| 111 | Broad metatarsal (HP:0001783) | 1.97125957 |
| 112 | Flat acetabular roof (HP:0003180) | 1.96987173 |
| 113 | Spinal cord compression (HP:0002176) | 1.95889968 |
| 114 | Progressive inability to walk (HP:0002505) | 1.93853633 |
| 115 | Neurofibrillary tangles (HP:0002185) | 1.92833377 |
| 116 | Bowel incontinence (HP:0002607) | 1.92783485 |
| 117 | Onion bulb formation (HP:0003383) | 1.92270507 |
| 118 | Primary atrial arrhythmia (HP:0001692) | 1.89028917 |
| 119 | Alkalosis (HP:0001948) | 1.88938631 |
| 120 | Atrial fibrillation (HP:0005110) | 1.88229100 |
| 121 | Insomnia (HP:0100785) | 1.88138185 |
| 122 | Deep palmar crease (HP:0006191) | 1.87879589 |
| 123 | Spastic tetraparesis (HP:0001285) | 1.87625496 |
| 124 | Abnormality of saccadic eye movements (HP:0000570) | 1.86660016 |
| 125 | Alveolar cell carcinoma (HP:0006519) | 1.85711017 |
| 126 | Obsessive-compulsive behavior (HP:0000722) | 1.83204854 |
| 127 | Adrenal overactivity (HP:0002717) | 1.82656804 |
| 128 | Growth hormone excess (HP:0000845) | 1.81660972 |
| 129 | Neoplasm of the heart (HP:0100544) | 1.81055061 |
| 130 | Ileus (HP:0002595) | 1.79523321 |
| 131 | Insidious onset (HP:0003587) | 1.79352840 |
| 132 | Termporal pattern (HP:0011008) | 1.79352840 |
| 133 | Aplasia involving bones of the extremities (HP:0009825) | 1.79245607 |
| 134 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.79245607 |
| 135 | Aplasia of the phalanges of the hand (HP:0009802) | 1.79245607 |
| 136 | Cerebral inclusion bodies (HP:0100314) | 1.79145456 |
| 137 | Delusions (HP:0000746) | 1.78814380 |
| 138 | Multifactorial inheritance (HP:0001426) | 1.77976370 |
| 139 | Supraventricular tachycardia (HP:0004755) | 1.76734953 |
| 140 | Generalized hypotonia (HP:0001290) | 1.76594245 |
| 141 | Thin bony cortex (HP:0002753) | 1.74932757 |
| 142 | Confusion (HP:0001289) | 1.73701193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 8.32094456 |
| 2 | NTRK3 | 3.79751137 |
| 3 | MAP3K9 | 3.55895189 |
| 4 | MST1R | 3.44649158 |
| 5 | KSR2 | 3.12946985 |
| 6 | MATK | 2.92089276 |
| 7 | DAPK2 | 2.87129849 |
| 8 | FGFR4 | 2.80740198 |
| 9 | PRKD3 | 2.74037699 |
| 10 | RIPK4 | 2.68985856 |
| 11 | CAMKK1 | 2.53962313 |
| 12 | EPHA2 | 2.14376683 |
| 13 | SIK1 | 2.12192772 |
| 14 | TAOK1 | 2.06769784 |
| 15 | MAP3K13 | 2.04347188 |
| 16 | ARAF | 2.03952703 |
| 17 | MINK1 | 2.01901045 |
| 18 | KSR1 | 1.90987007 |
| 19 | FES | 1.90700111 |
| 20 | PRKCI | 1.80047003 |
| 21 | MAP3K2 | 1.78501186 |
| 22 | NTRK1 | 1.76951492 |
| 23 | PTK2 | 1.68884605 |
| 24 | TESK1 | 1.67358686 |
| 25 | CAMKK2 | 1.62311666 |
| 26 | PAK6 | 1.61187384 |
| 27 | NTRK2 | 1.60421582 |
| 28 | ERN1 | 1.55097785 |
| 29 | MAP3K4 | 1.54837836 |
| 30 | TYRO3 | 1.53546808 |
| 31 | DAPK1 | 1.46422055 |
| 32 | * CDK5 | 1.43115110 |
| 33 | PKN2 | 1.42039029 |
| 34 | MET | 1.39354746 |
| 35 | PIK3CA | 1.37955916 |
| 36 | CDK12 | 1.37050616 |
| 37 | TNIK | 1.35620245 |
| 38 | SIK2 | 1.32705425 |
| 39 | RAF1 | 1.32666894 |
| 40 | MARK1 | 1.24826600 |
| 41 | PINK1 | 1.15755079 |
| 42 | STK38 | 1.14911037 |
| 43 | LMTK2 | 1.13469349 |
| 44 | MAP2K6 | 1.12668171 |
| 45 | PRPF4B | 1.09078948 |
| 46 | SGK223 | 1.07847659 |
| 47 | SGK494 | 1.07847659 |
| 48 | NEK1 | 1.07214592 |
| 49 | PRKCH | 1.04606958 |
| 50 | RIPK1 | 1.03076257 |
| 51 | MAP2K7 | 0.97635474 |
| 52 | BMPR2 | 0.96617956 |
| 53 | SGK3 | 0.95498197 |
| 54 | SGK2 | 0.94366343 |
| 55 | MAP3K1 | 0.89342667 |
| 56 | TRIB3 | 0.88712548 |
| 57 | MAP2K4 | 0.88694523 |
| 58 | MARK2 | 0.87562066 |
| 59 | PDPK1 | 0.87424367 |
| 60 | STK11 | 0.85603118 |
| 61 | ALK | 0.83796147 |
| 62 | STK39 | 0.82664648 |
| 63 | CASK | 0.80533812 |
| 64 | PRKCG | 0.79336167 |
| 65 | PDK1 | 0.78824873 |
| 66 | LATS2 | 0.78667635 |
| 67 | UHMK1 | 0.77718653 |
| 68 | RET | 0.77561506 |
| 69 | MAP2K1 | 0.75420184 |
| 70 | PTK6 | 0.73262678 |
| 71 | TNK2 | 0.73159322 |
| 72 | GRK5 | 0.71707064 |
| 73 | CAMK1 | 0.71653122 |
| 74 | CAMK2B | 0.69122201 |
| 75 | PTK2B | 0.68891269 |
| 76 | CAMK2A | 0.66387891 |
| 77 | NEK6 | 0.64797419 |
| 78 | PAK3 | 0.58120318 |
| 79 | WNK1 | 0.57629349 |
| 80 | PRKD2 | 0.57353391 |
| 81 | DAPK3 | 0.56686924 |
| 82 | RPS6KA3 | 0.55361827 |
| 83 | BRSK1 | 0.54850156 |
| 84 | FYN | 0.54780324 |
| 85 | * SGK1 | 0.54135045 |
| 86 | MAP3K6 | 0.53834825 |
| 87 | NME1 | 0.53093138 |
| 88 | MAP3K11 | 0.53066058 |
| 89 | CAMK4 | 0.52973776 |
| 90 | MOS | 0.52809448 |
| 91 | ROCK1 | 0.52772946 |
| 92 | PRKCZ | 0.52767076 |
| 93 | MAPK12 | 0.51632304 |
| 94 | DMPK | 0.49460237 |
| 95 | CDK3 | 0.45149655 |
| 96 | BRAF | 0.43975178 |
| 97 | MAPK13 | 0.43683803 |
| 98 | TAOK2 | 0.43620832 |
| 99 | MAPK10 | 0.43311156 |
| 100 | RPS6KA2 | 0.42456817 |
| 101 | MAP3K12 | 0.41970668 |
| 102 | PRKAA1 | 0.40794705 |
| 103 | CDK19 | 0.40746685 |
| 104 | * CDK14 | 0.39049690 |
| 105 | * CDK18 | 0.37892894 |
| 106 | OXSR1 | 0.37706215 |
| 107 | SRC | 0.36904434 |
| 108 | PDGFRA | 0.36772544 |
| 109 | CAMK2G | 0.36768918 |
| 110 | DDR2 | 0.35790189 |
| 111 | BMX | 0.35758009 |
| 112 | * CDK15 | 0.34932303 |
| 113 | PHKG2 | 0.34832287 |
| 114 | PHKG1 | 0.34832287 |
| 115 | CDC42BPA | 0.34726849 |
| 116 | SCYL2 | 0.32692178 |
| 117 | CAMK2D | 0.31710680 |
| 118 | PLK2 | 0.30314628 |
| 119 | * PRKCB | 0.28765101 |
| 120 | PRKCA | 0.28703178 |
| 121 | MAP3K7 | 0.27865364 |
| 122 | FGFR2 | 0.27634720 |
| 123 | HCK | 0.27230047 |
| 124 | * CDK11A | 0.26978470 |
| 125 | ERBB2 | 0.26303644 |
| 126 | PRKCE | 0.25479990 |
| 127 | PRKD1 | 0.25441763 |
| 128 | * PRKACA | 0.23966873 |
| 129 | PRKG2 | 0.23739000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.88163911 |
| 2 | Morphine addiction_Homo sapiens_hsa05032 | 2.88100051 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.72234560 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.71326359 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.63760837 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.61695523 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.59131504 |
| 8 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.52590951 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.44824978 |
| 10 | * Cocaine addiction_Homo sapiens_hsa05030 | 2.44583144 |
| 11 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.29137202 |
| 12 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.25545796 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.25367701 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.24374488 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.15466734 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 2.09720323 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 2.05198864 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94845560 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.90287521 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.89750291 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.89013634 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.76645665 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.76242082 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.74511356 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.67359680 |
| 26 | Gap junction_Homo sapiens_hsa04540 | 1.62777478 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.47675047 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47291486 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46755721 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.37760551 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.34287711 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 1.32380809 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30992335 |
| 34 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30790517 |
| 35 | Mineral absorption_Homo sapiens_hsa04978 | 1.30713686 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29059496 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.21581964 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18709105 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.17731680 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.14929733 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10802207 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07695795 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04480085 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04080075 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03568194 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.02057267 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98719987 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98221731 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94753027 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94353929 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.91508720 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.91284035 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88752362 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85910817 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85757332 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83749602 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83380345 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82137725 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.81290455 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81287534 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.80886602 |
| 62 | * Alcoholism_Homo sapiens_hsa05034 | 0.80196508 |
| 63 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79784337 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79381667 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 0.78805864 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77458193 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77297668 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76434420 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76064150 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75947320 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75343829 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75133998 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74563285 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70893948 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70796973 |
| 76 | Axon guidance_Homo sapiens_hsa04360 | 0.70136373 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.68649838 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67611192 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65409242 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64075136 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63306637 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62092712 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61706195 |
| 84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.61631800 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61533619 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59691838 |
| 87 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.59025664 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56910881 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56017854 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55920263 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55154018 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54795766 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53499411 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52639235 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52478126 |
| 96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52146493 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51518535 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51200276 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49051324 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47308888 |
| 101 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47285586 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47265664 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46896463 |
| 104 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46504909 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45720344 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.45538623 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44420917 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.43947622 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42835815 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.41698957 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40285362 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38334630 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38127593 |
| 114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38121650 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37913096 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37019404 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35196980 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35107797 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34947502 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34476687 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34128457 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33087317 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31288595 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30805773 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30284021 |
| 126 | Tight junction_Homo sapiens_hsa04530 | 0.27459118 |
| 127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25685843 |
| 128 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.24910222 |
| 129 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22748989 |
| 130 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20436581 |

